This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural properties, which make it a potential candidate for drug development. It is often explored for its activity on central nervous system (CNS) targets, particularly as a modulator of dopamine receptors. Researchers investigate its potential in treating neurological and psychiatric disorders, such as schizophrenia, Parkinson's disease, and other dopamine-related conditions. Additionally, its unique benzazepine core structure allows for further chemical modifications, enabling the development of novel therapeutic agents with improved efficacy and selectivity. The compound is also studied in preclinical research to understand its pharmacokinetics, metabolism, and safety profile, which are critical for advancing it into clinical trials.